Search Results - "Merkulov, Evgeny"

Mixed-valence hydrated iron fluoridotitanate: Crystal structure and thermal behavior by Udovenko, Anatoly A., Goreshnik, Evgeny A., Merkulov, Evgeny B., Laptash, Natalia M.

“…•High quality mixed-valence single crystals of hydrated iron hexafluoridotitanate (HITF) were obtained.•Crystal structures of RT and LT modifications of HITF…”
Get full text

Synthesis, crystal structure, and properties of new compounds [NH4]4[SbF4]2[NbOF5], K4[SbF4]2[NbOF5], and [NH4]4[SbF4]2[SnF6] by Merkulov, Evgeny B., Voit, Elena I., Gerasimenko, Andrey V.

“…[Display omitted] •Three new compounds [(K/NH4)4]4[SbF4]2[NbOF5/SnF6] were synthesized.•The crystal structures of the compounds have been determined by…”
Get full text

Synthesis, crystal structure, 19F, 1H NMR, thermogravimetry, and DSC investigation of indium(III) fluoride complexes with β-alanine amino acid by Davidovich, Ruven L., Kavun, Valery Ya, Udovenko, Anatoly A., Polyantsev, Mikhail M., Merkulov, Evgeny B., Logvinova, Vera B., Gerasimenko, Andrey V.

“…Disordered [InF5(H2O)]2– anion and (β-AlaH)+ cation in the structure of (β-AlaH)2[InF5(H2O)]·2H2O appear on the left. The dependences of the NMR spectra width…”
Get full text

Right ventricle free wall rupture during transcatheter occluder implantation in a patient with postinfarction rupture of the interventricular septum and COVID-19-associated myocarditis. Case report by Pevzner, D V, Sukhinina, T S, Anufriev, E N, Kostritca, N S, Avetisyan, E A, Shitov, V N, Kurilina, E V, Osiev, A G, Merkulov, E V, Tereshchenko, A S, Boytsov, S A

“…Intraventricular septum rupture is a rare mechanic complication of myocardial infarction associated with high mortality. This case describes STEMI in recovered…”
Get full text

A Randomized Trial Comparing Short versus Prolonged Hemostasis with Rescue Recanalization by Ipsilateral Ulnar Artery Compression: Impact on Radial Artery Occlusion—The RESCUE-RAO Trial by Balakhonova., Tatyana V, Samko, Anatoliy N., Merkulov, Evgeny V., Pogorelova, Olga A., Arutyunyan, Goar K., Bernat, Ivo, Bertrand, Olivier F., Tereshchenko, Andrey S., Provatorov, Sergey I., Sedaghat, Alexander, Ognerubov, Dmitrii V., Tripoten, Maria I.

“…Background. Despite the enormous benefits of radial access, this route is associated with a risk of radial artery occlusion (RAO). Objective. We compared the…”
Get full text

Risk factors of coronary artery disease in rheumatoid arthritis estimated on the basis of the three-year observation by Krougly, Lev B., Fomicheva, Olga A., Balahonova, Tatiana V., Merkulov, Evgeny V., Karpov, Yuri A., Popkova, Tatiana V., Nasonov, Evgeny L.

Get full text

Atherosclerosis progression in rheumatoid arthritis estimated on the basis of the three-year observation by Krougly, Lev B., Fomicheva, Olga A., Balahonova, Tatiana V., Merkulov, Evgeny V., Karpov, Yuri A., Popkova, Tatiana V., Nasonov, Evgeny L.

Get full text

Patent foramen ovale as the cause of recurrent embolic strokes. Case report by Komarov, Andrey L., Krivosheeva, Elena N., Makeev, Maksim I., Merkulov, Evgeny V., Tripoten, Maria I., Panchenko, Elizaveta P.

“…А clinical case of a young patient with recurrent ischemic strokes is presented. The problems of diagnostic embolic strokes are discussed. We set out the…”
Get full text

Analysis of the causes of repeat stenosis of the coronary arteries after elective stenting in patients with stable angina pectoris by Filatova, A Y, Osokina, A K, Potekhina, A V, Romasov, I V, Kotkina, T I, Shchinova, A M, Noeva, E A, Arefieva, T I, Barabanova, E A, Merkulov, E V, Samko, A N, Provatorov, S I

“…Coronary stenting is the evidence-based treatment approach of stable angina. The objective was to determine the incidence of restenosis or atherosclerosis…”
Get full text

THE ENDOVASCULAR PREVENTION OF THROMBOEMBOLISM IN ATRIAL FIBRILLATION by Al-Ayyubi, Rami N., Merkulov, Evgeny V., Tereschenko, Andrey S., Pevzner, Dmitry V., Zhukova, Natalia S., Samko, Anatoly N., Guchaev, Ruslan V.

“…The article dwells upon the various strategies for prevention of thromboembolic events in patients with atrial fibrillation. The main focus is put on the…”
Get full text

ANTITHROMBOTIC TREATMENT AFTER THE LEFT ATRIAL APPENDAGE OCCLUSION: IMPACT ON CLINICAL OUTCOMES IN RUSSIAN PROSPECTIVE REGISTRY by Merkulova, Irina, Pevzner, Dmitriy, Rytova, Yulia, Shakhmatova, Olga, Avetisyan, Eric, Merkulov, Evgeny

Get full text

Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry by Boersma, Lucas V A, Schmidt, Boris, Betts, Timothy R, Sievert, Horst, Tamburino, Corrado, Teiger, Emmanuel, Pokushalov, Evgeny, Kische, Stephan, Schmitz, Thomas, Stein, Kenneth M, Bergmann, Martin W

“…Left atrial appendage closure is a non-pharmacological alternative for stroke prevention in high-risk patients with non-valvular atrial fibrillation. The…”
Get full text

Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage by Boersma, Lucas V, Ince, Hueseyin, Kische, Stephan, Pokushalov, Evgeny, Schmitz, Thomas, Schmidt, Boris, Gori, Tommaso, Meincke, Felix, Protopopov, Alexey Vladimir, Betts, Timothy, Mazzone, Patrizio, Foley, David, Grygier, Marek, Sievert, Horst, De Potter, Tom, Vireca, Elisa, Stein, Kenneth, Bergmann, Martin W, Al Nooryani, Arif, Fiedler, Thomas, Senatore, Gaetano, Brigadeau, François, Defaye, Pascal, Teiger, Emmanuel, Bonnet, Jean-Louis, Wald, Christof, Szili-Torok, Tamas, Tschishow, Wladimir, Crossland, David, Vahanian, Alec, Cruz-Gonzalez, Ignacio, Thambo, Jean-Benoit, Al Smadi, Faisal, Mudra, Harald, Molitoris, Robin, Folkeringa, Richard, Stevenhagen, Yorick, Gras, Daniel, Tamburino, Corrado, Molon, Giulio, Spence, Mark, Infante Oliveira, Eduardo, Merkulov, Evgeny, Sukiennik, Adam, Wong, Tom, Busch, Mathias, Boldt, Leif-Hendrik, Nickenig, Georg, Neef, Martin

“…BACKGROUND:Left atrial appendage occlusion with WATCHMAN has emerged as viable alternative to vitamin K antagonists in randomized controlled trials. Evaluating…”
Get full text

Dual luminescence of polymers with grafted BF2-benzoylacetonate groups by Fedorenko, Elena V., Mirochnik, Anatolii G., Merkulov, Evgeny B.

“…Polymers with varied contents of BF2-benzoylacetonate (BF2-BAc) groups have been synthesized by the reaction of double acylation of copolymers of methyl…”
Get full text

TCT-385 The MADS Classification in Patients Undergoing Left Main Percutaneous Coronary Intervention: Technique Analysis From the IDEAL LM Trial by Chang, Chun-Chin, Onuma, Yoshinobu, Lesiak, Maciej, Merkulov, Evgeny, Anderson, Richard, Kretov, Evgeny, Barragan, Paul, Oldroyd, Keith, Van Geuns, Robert-Jan

Get full text

Optical Coherence Tomography Assessment for Percutaneous Coronary Intervention of the Left Main Artery by Chang, Chun Chin, Onuma, Yoshinobu, Lesiak, Maciej, Merkulov, Evgeny, Anderson, Richard, Kretov, Evgeny, Barragan, Paul, Oldroyd, Keith G., van Geuns, Robert-Jan

Get full text

Clinical and echocardiographic risk factors for device-related thrombus after left atrial appendage closure: an analysis from the multicenter EUROC-DRT registry by Vij, Vivian, Piayda, Kerstin, Nelles, Dominik, Gloekler, Steffen, Galea, Roberto, Fürholz, Monika, Meier, Bernhard, Valgimigli, Marco, O’Hara, Gilles, Arzamendi, Dabit, Agudelo, Victor, Asmarats, Lluis, Freixa, Xavier, Flores-Umanzor, Eduardo, De Backer, Ole, Sondergaard, Lars, Nombela-Franco, Luis, McInerney, Angela, Korsholm, Kasper, Nielsen-Kudsk, Jens Erik, Afzal, Shazia, Zeus, Tobias, Operhalski, Felix, Schmidt, Boris, Montalescot, Gilles, Guedeney, Paul, Iriart, Xavier, Miton, Noelie, Saw, Jacqueline, Gilhofer, Thomas, Fauchier, Laurent, Veliqi, Egzon, Meincke, Felix, Petri, Nils, Nordbeck, Peter, Ognerubov, Dmitrii, Merkulov, Evgeny, Cruz-González, Ignacio, Gonzalez-Ferreiro, Rocio, Bhatt, Deepak L., Laricchia, Alessandra, Mangieri, Antonio, Omran, Heyder, Schrickel, Jan Wilko, Rodes-Cabau, Josep, Sievert, Horst, Nickenig, Georg, Sedaghat, Alexander

“…Background Data on Device-related Thrombus (DRT) after left atrial appendage closure (LAAC) remain scarce. This study aimed to investigate risk factors for DRT…”
Get full text

Bioabsorbable polymer drug-eluting stents with 4-month dual antiplatelet therapy versus durable polymer drug-eluting stents with 12-month dual antiplatelet therapy in patients with left main coronary artery disease: the IDEAL-LM randomised trial by van Geuns, Robert-Jan, Chun-Chin, Chang, McEntegart, Margaret B, Merkulov, Evgeny, Kretov, Evgeny, Lesiak, Maciej, O'Kane, Peter, Hanratty, Colm G, Bressollette, Erwan, Silvestri, Marc, Wlodarczak, Adrian, Barragan, Paul, Anderson, Richard, Protopopov, Aleksey, Peace, Aaron, Menown, Ian, Rocchiccioli, Paul, Onuma, Yoshinobu, Oldroyd, Keith G

“…Improvements in drug-eluting stent design have led to a reduced frequency of repeat revascularisation and new biodegradable polymer coatings may allow a…”
Get full text

Optical Coherence Tomography Assessment for Percutaneous Coronary Intervention of the Left Main Artery: The IDEAL-LM Trial by Chang, Chun Chin, Onuma, Yoshinobu, Lesiak, Maciej, Merkulov, Evgeny, Anderson, Richard, Kretov, Evgeny, Barragan, Paul, Oldroyd, Keith G., van Geuns, Robert-Jan

Get full text

Reduced duration of dual antiplatelet therapy using an improved drug-eluting stent for percutaneous coronary intervention of the left main artery in a real-world, all-comer population: Rationale and study design of the prospective randomized multicenter IDEAL-LM trial by Lemmert, Miguel E., Oldroyd, Keith, Barragan, Paul, Lesiak, Maciej, Byrne, Robert A., Merkulov, Evgeny, Daemen, Joost, Onuma, Yoshinobu, Witberg, Karen, van Geuns, Robert-Jan

“…Continuous improvements in stent technology make percutaneous coronary intervention (PCI) a potential alternative to surgery in selected patients with…”
Get full text